IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $657,260 | +85.1% | 16,019 | +79.7% | 0.10% | +56.5% |
| Q2 2021 | $355,000 | -85.3% | 8,912 | -79.2% | 0.06% | -80.3% |
| Q4 2020 | $2,417,000 | +695.1% | 42,747 | +568.1% | 0.32% | +707.7% |
| Q3 2020 | $304,000 | -77.3% | 6,398 | -71.9% | 0.04% | -77.3% |
| Q2 2020 | $1,342,000 | -19.5% | 22,765 | -35.4% | 0.17% | -22.2% |
| Q1 2020 | $1,667,000 | +149.6% | 35,254 | +218.9% | 0.22% | +99.1% |
| Q4 2019 | $668,000 | – | 11,055 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |